Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue.

Next Previous
X
Search
Trial Profile

Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue.

Status: Discontinued
Phase of Trial: Phase II/III

Latest Information Update: 30 Nov 2023

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs PG 2 (Primary)
  • Indications Fatigue
  • Focus Therapeutic Use
  • Sponsors PhytoHealth

    • Most Recent Events

    • 03 Nov 2015 Status changed from recruiting to discontinued as per ClinicalTrials.gov record.
    • 05 Jun 2009 Planned end date changed from 1 Aug 2008 to 1 Dec 2010 as reported by ClinicalTrials.gov.
    • 22 Oct 2007 Status changed from initiated to recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top